These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12000494)

  • 1. Bee-venom allergy in children: long-term predictive value of standardized challenge tests.
    Schuetze GE; Forster J; Hauk PJ; Friedl K; Kuehr J
    Pediatr Allergy Immunol; 2002 Feb; 13(1):18-23. PubMed ID: 12000494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venom immunotherapy for preventing allergic reactions to insect stings.
    Boyle RJ; Elremeli M; Hockenhull J; Cherry MG; Bulsara MK; Daniels M; Oude Elberink JN
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008838. PubMed ID: 23076950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
    Ruëff F; Wenderoth A; Przybilla B
    J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A; Yogev A; Confino-Cohen R
    Int Arch Allergy Immunol; 2011; 156(1):90-8. PubMed ID: 21447964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of re-sting reactions in children with moderate to severe venom hypersensitivity.
    Ertoy Karagol HI; Bakirtas A; Yilmaz O; Topal E; Arga M; Demirsoy MS; Turktas I
    Eur J Pediatr; 2015 Jul; 174(7):891-6. PubMed ID: 25563216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exclusive Bee Venom Allergy: Risk Factors and Outcome of Immunotherapy.
    Rosman Y; Nashef F; Cohen-Engler A; Meir-Shafrir K; Lachover-Roth I; Confino-Cohen R
    Int Arch Allergy Immunol; 2019; 180(2):128-134. PubMed ID: 31216540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deliberate bee sting challenge of patients receiving maintenance venom immunotherapy at 3-month intervals.
    Goldberg A; Confino-Cohen R; Mekori YA
    J Allergy Clin Immunol; 1994 Jun; 93(6):997-1001. PubMed ID: 8006322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
    Goldberg A; Confino-Cohen R
    J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sting challenge: indications and execution].
    Ruëff F; Przybilla B
    Hautarzt; 2014 Sep; 65(9):796-801. PubMed ID: 25234628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (ÖGAI).
    Ruëff F; Bauer A; Becker S; Brehler R; Brockow K; Chaker AM; Darsow U; Fischer J; Fuchs T; Gerstlauer M; Gernert S; Hamelmann E; Hötzenecker W; Klimek L; Lange L; Merk H; Mülleneisen NK; Neustädter I; Pfützner W; Sieber W; Sitter H; Skudlik C; Treudler R; Wedi B; Wöhrl S; Worm M; Jakob T
    Allergol Select; 2023; 7():154-190. PubMed ID: 37854067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients.
    Lerch E; Müller UR
    J Allergy Clin Immunol; 1998 May; 101(5):606-12. PubMed ID: 9600496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
    Nittner-Marszalska M; Cichocka-Jarosz E; Małaczyńska T; Kraluk B; Rosiek-Biegus M; Kosinska M; Pawłowicz R; Lis G
    J Investig Allergol Clin Immunol; 2016; 26(1):40-7. PubMed ID: 27012015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bee and wasp venom allergy in Turkey.
    Kalyoncu AF; Demir AU; Ozcan U; Ozkuyumcu C; Sahin AA; Bariş YI
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):408-12. PubMed ID: 9109709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of venom immunotherapy.
    Hafner T; DuBuske L; Kosnik M
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):162-5. PubMed ID: 18320918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunologic follow-up of patients who stop venom immunotherapy.
    Keating MU; Kagey-Sobotka A; Hamilton RG; Yunginger JW
    J Allergy Clin Immunol; 1991 Sep; 88(3 Pt 1):339-48. PubMed ID: 1890261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A twenty-two-year experience with Hymenoptera venom immunotherapy in a US pediatric tertiary care center 1996-2018.
    Albuhairi S; El Khoury K; Yee C; Schneider L; Rachid R
    Ann Allergy Asthma Immunol; 2018 Dec; 121(6):722-728.e1. PubMed ID: 30102964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of immunotherapy with venom in children with allergy to insect stings.
    Valentine MD; Schuberth KC; Kagey-Sobotka A; Graft DF; Kwiterovich KA; Szklo M; Lichtenstein LM
    N Engl J Med; 1990 Dec; 323(23):1601-3. PubMed ID: 2098016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effectiveness of hymenoptera venom immunotherapy: a prospective observational multicenter study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivity.
    Ruëff F; Przybilla B; Biló MB; Müller U; Scheipl F; Seitz MJ; Aberer W; Bodzenta-Lukaszyk A; Bonifazi F; Campi P; Darsow U; Haeberli G; Hawranek T; Küchenhoff H; Lang R; Quercia O; Reider N; Schmid-Grendelmeier P; Severino M; Sturm GJ; Treudler R; Wüthrich B
    PLoS One; 2013; 8(5):e63233. PubMed ID: 23700415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgE-Api m 4 Is Useful for Identifying a Particular Phenotype of Bee Venom Allergy.
    Ruiz B; Serrano P; Moreno C
    J Investig Allergol Clin Immunol; 2016; 26(6):355-361. PubMed ID: 27996941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Follow-Up of Children after Venom Immunotherapy: Low Adherence to Anaphylaxis Guidelines.
    Fiedler C; Miehe U; Treudler R; Kiess W; Prenzel F
    Int Arch Allergy Immunol; 2017; 172(3):167-172. PubMed ID: 28380475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.